These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22045354)

  • 1. The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer.
    Balch C; Nephew KP
    Cancer Biomark; 2010-2011; 8(4-5):203-21. PubMed ID: 22045354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minireview: epigenetic changes in ovarian cancer.
    Balch C; Fang F; Matei DE; Huang TH; Nephew KP
    Endocrinology; 2009 Sep; 150(9):4003-11. PubMed ID: 19574400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.
    Bapat SA; Jin V; Berry N; Balch C; Sharma N; Kurrey N; Zhang S; Fang F; Lan X; Li M; Kennedy B; Bigsby RM; Huang TH; Nephew KP
    Epigenetics; 2010; 5(8):716-29. PubMed ID: 20676026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in ovarian cancer.
    Seeber LM; van Diest PJ
    Methods Mol Biol; 2012; 863():253-69. PubMed ID: 22359298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of cancer-associated genes in ovarian cancer.
    Kwon MJ; Shin YK
    Int J Mol Sci; 2011 Jan; 12(2):983-1008. PubMed ID: 21541038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
    Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
    Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tubal epigenome - An emerging target for ovarian cancer.
    Reavis HD; Drapkin R
    Pharmacol Ther; 2020 Jun; 210():107524. PubMed ID: 32197795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of epigenomics in ovarian and endometrial cancers.
    Balch C; Matei DE; Huang TH; Nephew KP
    Epigenomics; 2010 Jun; 2(3):419-47. PubMed ID: 22121902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
    Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma.
    Braga EA; Loginov VI; Filippova EA; Burdennyi AM; Pronina IV; Kazubskaya TP; Khodyrev DS; Utkin DO; Kushlinskii DN; Adamyan LV; Kuslinskii NE
    Bull Exp Biol Med; 2018 Dec; 166(2):253-256. PubMed ID: 30488208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic biomarkers in epithelial ovarian cancer.
    Gloss BS; Samimi G
    Cancer Lett; 2014 Jan; 342(2):257-63. PubMed ID: 22245949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer: a modified epigenome.
    Van Den Broeck A; Ozenne P; Eymin B; Gazzeri S
    Cell Adh Migr; 2010; 4(1):107-13. PubMed ID: 20139698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current data and future perspectives on DNA methylation in ovarian cancer (Review).
    Fu M; Deng F; Chen J; Fu L; Lei J; Xu T; Chen Y; Zhou J; Gao Q; Ding H
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.
    Srivastava AK; Banerjee A; Cui T; Han C; Cai S; Liu L; Wu D; Cui R; Li Z; Zhang X; Xie G; Selvendiran K; Patnaik S; Karpf AR; Liu J; Cohn DE; Wang QE
    Cancer Res; 2019 May; 79(9):2314-2326. PubMed ID: 30894370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.
    Muñoz-Galván S; Felipe-Abrio B; Verdugo-Sivianes EM; Perez M; Jiménez-García MP; Suarez-Martinez E; Estevez-Garcia P; Carnero A
    Mol Cancer; 2020 Jan; 19(1):7. PubMed ID: 31926547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.
    Pajares MJ; Alemany-Cosme E; Goñi S; Bandres E; Palanca-Ballester C; Sandoval J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SiRNA and epigenetic aberrations in ovarian cancer.
    Mirzaei H; Yazdi F; Salehi R; Mirzaei HR
    J Cancer Res Ther; 2016; 12(2):498-508. PubMed ID: 27461600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mathematical model of bimodal epigenetic control of miR-193a in ovarian cancer stem cells.
    Cheng FH; Aguda BD; Tsai JC; Kochańczyk M; Lin JM; Chen GC; Lai HC; Nephew KP; Hwang TW; Chan MW
    PLoS One; 2014; 9(12):e116050. PubMed ID: 25545504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.
    Singh AK; Chandra N; Bapat SA
    Clin Cancer Res; 2015 Nov; 21(22):5151-63. PubMed ID: 26130461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.